Kimberly-Clark (NASDAQ:KMB) Given New $110.00 Price Target at BNP Paribas Exane

Kimberly-Clark (NASDAQ:KMB) had its price objective hoisted by stock analysts at BNP Paribas Exane from $101.00 to $110.00 in a research report issued on Friday, Benzinga reports. The firm presently has a “neutral” rating on the stock. BNP Paribas Exane’s price objective would suggest a potential upside of 5.11% from the company’s current price.

Several other analysts have also recently commented on the stock. Wells Fargo & Company lowered their target price on shares of Kimberly-Clark from $105.00 to $100.00 and set an “equal weight” rating for the company in a research note on Monday, October 5th. UBS Group upped their price objective on Kimberly-Clark from $115.00 to $116.00 and gave the stock a “neutral” rating in a report on Wednesday, August 5th. TD Cowen reduced their price target on shares of Kimberly-Clark from $104.00 to $97.00 and set a “hold” rating on the stock in a research report on Tuesday. Weiss Ratings upgraded Kimberly-Clark from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, July 28th. Finally, Bank of America decreased their target price on shares of Kimberly-Clark from $122.00 to $120.00 and set a “buy” rating for the company in a research note on Friday, September 25th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $116.50.

Kimberly-Clark Price Performance

KMB traded up $0.58 during midday trading on Friday, reaching $104.65. 2,090,113 shares of the company’s stock were exchanged, compared to its average volume of 4,824,296. Kimberly-Clark has a 1-year low of $92.42 and a 1-year high of $123.09. The company has a debt-to-equity ratio of 3.45, a current ratio of 0.91 and a quick ratio of 0.69. The business’s 50-day moving average price is $102.86 and its 200 day moving average price is $102.59. The stock has a market capitalization of $34.80 billion, a PE ratio of 17.80, a P/E/G ratio of 5.08 and a beta of 0.25.

Kimberly-Clark (NASDAQ:KMB) last announced its earnings results on Tuesday, August 4th. The company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $2.01 by ($0.21). The company had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.22 billion. Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. Kimberly-Clark’s quarterly revenue was up .6% compared to the same quarter last year. During the same quarter last year, the company posted $1.92 EPS. As a group, equities analysts anticipate that Kimberly-Clark will post 7.35 EPS for the current fiscal year.

Institutional Trading of Kimberly-Clark

Several hedge funds have recently made changes to their positions in KMB. BlackRock Inc. bought a new stake in Kimberly-Clark in the second quarter valued at $3,547,915,000. Bank of America Corp DE boosted its position in shares of Kimberly-Clark by 3.3% during the 2nd quarter. Bank of America Corp DE now owns 6,881,641 shares of the company’s stock valued at $755,398,000 after purchasing an additional 219,742 shares in the last quarter. Thornburg Investment Management Inc. acquired a new position in Kimberly-Clark in the second quarter worth approximately $632,373,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Kimberly-Clark by 8.7% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,116,768 shares of the company’s stock worth $342,128,000 after purchasing an additional 249,832 shares during the period. Finally, Bank of New York Mellon Corp increased its position in shares of Kimberly-Clark by 0.9% in the first quarter. Bank of New York Mellon Corp now owns 2,237,904 shares of the company’s stock worth $215,891,000 after acquiring an additional 18,989 shares in the last quarter. Institutional investors own 76.29% of the company’s stock.

More Kimberly-Clark News

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: Kimberly-Clark reported preliminary third-quarter adjusted earnings per share of $1.70, above the FactSet consensus estimate of $1.58. The earnings beat helped drive the stock higher despite weaker sales. Kimberly-Clark preliminary adjusted EPS report
• Positive Sentiment: Management maintained its full-year 2026 financial outlook, providing reassurance that the quarter’s weakness is not currently expected to derail annual targets. The company expects organic sales growth to be approximately 100 basis points below weighted-average category growth. Kimberly-Clark preliminary third-quarter results
• Positive Sentiment: Reports that China cleared claims involving formamide in Kimberly-Clark products may reduce a regulatory and reputational overhang tied to the company’s Huggies diapers and could help stabilize its China business. Reuters report on Kimberly-Clark results and China claims
• Neutral Sentiment: Kimberly-Clark remains viewed as an income-oriented consumer staples company, but commentary highlights that its long dividend-raise streak is under pressure as profits shrink. Free cash flow still covers the dividend, although slower growth could limit future increases. Kimberly-Clark dividend growth report
• Negative Sentiment: Third-quarter sales are expected to decline, reflecting continued pressure from the China social-media backlash and softer operating performance. The earnings beat therefore appears driven more by profitability than by business growth. Wall Street Journal report on Kimberly-Clark sales outlook
• Negative Sentiment: TD Cowen cut its price target for KMB, signaling that analysts continue to see valuation or fundamental risks despite the preliminary earnings beat. TD Cowen Kimberly-Clark price target report

About Kimberly-Clark

Kimberly-Clark Corporation (NASDAQ:KMB) is a global personal care and consumer products company that develops and markets essential products for consumers and professional customers. Its portfolio includes products in the baby and childcare, adult care, feminine care, facial and bathroom tissue, and household categories.

The company’s well-known brands include Huggies diapers and wipes, Kleenex tissues, Kotex feminine care products, Cottonelle and Scott bathroom tissue, and Depend and Poise adult care products.